title: [Muroctasin, a muramyl dipeptide derivative].
abstract: This paper presents a review of studies on the metabolism, pharmacological and clinical properties of a new synthetic muramyl dipeptide derivative N2-/(N-acetylmuramoyl)-L-alanyl-D-isoglutaminyl/-N6-stearoyl-L-lysine(MD P- Lys(L18), muroctasin). Due to its effect on the number of peripheral blood leukocytes this compound is expected to be a useful drug for the treatment of leukopenia induced by cancer chemotherapy or radiation therapy.
authors.affiliation: Katedra i Zakład Histologii Akademii Medycznej, Gdańsku.
authors.forename: D
authors.initials: D
authors.lastname: Sosnowska
authors.forename: K
authors.initials: K
authors.lastname: Dzierzbicka
authors.forename: A
authors.initials: A
authors.lastname: Myśliwski
authors.forename: A M
authors.initials: AM
authors.lastname: Kołodziejczyk
mesh_terms: D000119:Acetylmuramyl-Alanyl-Isoglutamine / Q000031:analogs & derivatives* / Q000737:chemistry / Q000493:pharmacokinetics / Q000494:pharmacology; D000818:Animals; D005353:Fibronectins / Q000187:drug effects; D006410:Hematopoiesis / Q000187:drug effects; D006801:Humans; D007970:Leukopenia / Q000188:drug therapy
chemical_list: D005353:Fibronectins; D000119:Acetylmuramyl-Alanyl-Isoglutamine; C036866:romurtide
vernacular_title: Muroctasin, pochodna muramylodipeptydu.